Lorena Exposito

La Laguna, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.

Journal: Lupus science & medicine

Published: August 06, 2025

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2025

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study.

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study.

Journal: Seminars in arthritis and rheumatism

Published: May 08, 2025

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.

Journal: Lupus science & medicine

Published: April 13, 2025

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La.

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La.

Journal: Lupus

Published: April 01, 2025

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

Journal: Lupus science & medicine

Published: November 09, 2023

Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.

Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.

Journal: European journal of clinical investigation

Published: May 09, 2023

Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).

Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).

Journal: Seminars in arthritis and rheumatism

Published: March 13, 2023

Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry.

Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry.

Journal: Reumatologia clinica

Published: January 16, 2023

Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure.

Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure.

Journal: Seminars in arthritis and rheumatism

Published: August 12, 2021

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.

Journal: Scientific reports

Published: March 25, 2021

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Journal: Rheumatology (Oxford, England)

Published: February 14, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026